University of Houston: Risk of Overactive Bladder Associated With Medications for Dementia
January 07, 2022
January 07, 2022
HOUSTON, Texas, Jan. 7 (TNSJou) -- The University of Houston issued the following news release:
* * *
Study Reveals Increased Risk with Donepezil
* * *
A study from the University of Houston College of Pharmacy, and published in the Journal of the American Geriatrics Society, has evaluated the risk of overactive bladder (OAB) as a side effect of cholinesterase inhibitor (ChEI) drugs taken for dementia and Alzheimer's disease. The research . . .
* * *
Study Reveals Increased Risk with Donepezil
* * *
A study from the University of Houston College of Pharmacy, and published in the Journal of the American Geriatrics Society, has evaluated the risk of overactive bladder (OAB) as a side effect of cholinesterase inhibitor (ChEI) drugs taken for dementia and Alzheimer's disease. The research . . .